RBC Capital Maintains a Buy on Biogen (BIIB) With a $208 PT

finance.yahoo.com/news/rbc-capital-maintains-buy-biogen-151414761.html

In This Article:
Biogen Inc. (NASDAQ:BIIB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. In a report released on July 7, Brian Abrahams from RBC Capital maintained a Buy rating on Biogen Inc. (NASDAQ:BIIB) with a price target of $208.00.
A patient receiving…

This story appeared on finance.yahoo.com, 2025-07-10 15:14:14.
The Entire Business World on a Single Page. Free to Use →